Nahdi Medical Dividends and Buybacks
Dividend criteria checks 3/6
Nahdi Medical is a dividend paying company with a current yield of 4.71% that is well covered by earnings.
Key information
4.7%
Dividend yield
n/a
Buyback Yield
| Total Shareholder Yield | n/a |
| Future Dividend Yield | 5.0% |
| Dividend Growth | 29.3% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | ر.س5.500 |
| Payout ratio | 86% |
Recent dividend and buyback updates
Nahdi Medical (TADAWUL:4164) Has Announced A Dividend Of SAR2.50
Aug 03
Nahdi Medical (TADAWUL:4164) Is Paying Out A Dividend Of SAR3.00
Mar 21Recent updates
Returns On Capital Signal Tricky Times Ahead For Nahdi Medical (TADAWUL:4164)
Oct 18Nahdi Medical Company's (TADAWUL:4164) Share Price Is Matching Sentiment Around Its Earnings
Sep 13Nahdi Medical Company Beat Revenue Forecasts By 6.2%: Here's What Analysts Are Forecasting Next
Aug 07Nahdi Medical (TADAWUL:4164) Has Announced A Dividend Of SAR2.50
Aug 03Capital Allocation Trends At Nahdi Medical (TADAWUL:4164) Aren't Ideal
Jun 18There's No Escaping Nahdi Medical Company's (TADAWUL:4164) Muted Earnings
Apr 25Nahdi Medical (TADAWUL:4164) Is Paying Out A Dividend Of SAR3.00
Mar 21The Returns On Capital At Nahdi Medical (TADAWUL:4164) Don't Inspire Confidence
Jan 07Analyst Estimates: Here's What Brokers Think Of Nahdi Medical Company (TADAWUL:4164) After Its First-Quarter Report
Aug 07Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Jul 25Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital
Mar 22Nahdi Medical Company's (TADAWUL:4164) Price Is Out Of Tune With Earnings
Dec 13We Think Nahdi Medical's (TADAWUL:4164) Profit Is Only A Baseline For What They Can Achieve
Aug 20Are Investors Undervaluing Nahdi Medical Company (TADAWUL:4164) By 27%?
Aug 01Stability and Growth of Payments
Fetching dividends data
Stable Dividend: 4164 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 4164's dividend payments have increased, but the company has only paid a dividend for 2 years.
Dividend Yield vs Market
| Nahdi Medical Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (4164) | 4.7% |
| Market Bottom 25% (SA) | 1.7% |
| Market Top 25% (SA) | 4.7% |
| Industry Average (Consumer Retailing) | 4.0% |
| Analyst forecast (4164) (up to 3 years) | 5.0% |
Notable Dividend: 4164's dividend (4.71%) is higher than the bottom 25% of dividend payers in the SA market (1.69%).
High Dividend: 4164's dividend (4.71%) is low compared to the top 25% of dividend payers in the SA market (4.74%).
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (85.8%), 4164's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: At its current cash payout ratio (75.1%), 4164's dividend payments are covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 16:15 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nahdi Medical Company is covered by 7 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Duaa AlFadda | BofA Global Research |
| Michel Salameh | Citigroup Inc |
| Ahmed Moataz | EFG-Hermes Research |